Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality A Community-Based Study From the Netherlands

Journal of the American College of Cardiology

Volumn 66, Issue 9, 2015, Pages 1000-1007

  Vermond, Rob A ^a   Geelhoed, Bastiaan ^a   Verweij, Niek ^a   Tieleman, Robert G ^b   Van Der Harst, Pim ^a   Hillege, Hans L ^a   Van Gilst, Wiek H ^a   Van Gelder, Isabelle C ^a   Rienstra, Michiel ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

Author keywords

atrial fibrillation; comorbidities; epidemiology; heart failure; mortality; outcome

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE; AGED; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; NETHERLANDS; OBESITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE; VALVULAR HEART DISEASE; VERY ELDERLY; AGE DISTRIBUTION; CAUSE OF DEATH; CROSS-SECTIONAL STUDY; KAPLAN MEIER METHOD; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX RATIO; SURVIVAL;

ADULT; AGE DISTRIBUTION; AGED; ATRIAL FIBRILLATION; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 84940056860     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.06.1314     Document Type: Article

References (33)

1. B.P. Krijthe, A. Kunst, E.J. Benjamin, and et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060 Eur Heart J 34 2013 2746 2751
2. C.T. January, L.S. Wann, J.S. Alpert, and et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 64 2014 e1 e76
3. A.J. Camm, P. Kirchhof, G.Y. Lip, and et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
4. R.B. Schnabel, L.M. Sullivan, D. Levy, and et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study Lancet 373 2009 739 745
5. E.J. Benjamin, D. Levy, S.M. Vaziri, R.B. D'Agostino, A.J. Belanger, and P.A. Wolf Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study JAMA 271 1994 840 844
6. B.M. Psaty, T.A. Manolio, L.H. Kuller, and et al. Incidence of and risk factors for atrial fibrillation in older adults Circulation 96 1997 2455 2461
7. A.M. Chamberlain, S.K. Agarwal, A.R. Folsom, and et al. A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk In Communities [ARIC] study) Am J Cardiol 107 2011 85 91
8. Y. Miyasaka, M.E. Barnes, B.J. Gersh, and et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 2006 119 125
9. T. Wilke, A. Groth, S. Mueller, and et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients Europace 15 2013 486 493
10. H. Stefansdottir, T. Aspelund, V. Gudnason, and D.O. Arnar Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections Europace 13 2011 1110 1117
11. I.C. Van Gelder, L.M. Haegeli, A. Brandes, and et al. Rationale and current perspective for early rhythm control therapy in atrial fibrillation Europace 13 2011 1517 1525
12. P. Kirchhof, G.Y. Lip, I.C. Van Gelder, and et al. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options - a report from the 3rd atrial fibrillation competence NETwork/European Heart Rhythm Association consensus conference Europace 14 2012 8 27
13. P. Kirchhof, G. Breithardt, E. Aliot, and et al. Personalized management of atrial fibrillation: proceedings from the fourth Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference Europace 15 2013 1540 1556
14. F.P. Brouwers, R.A. de Boer, P. van der Harst, and et al. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND Eur Heart J 34 2013 1424 1431
15. E.M. Stuveling, H.L. Hillege, S.J. Bakker, and et al. C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease Atherosclerosis 172 2004 107 114
16. G.C. Linssen, S.J. Bakker, A.A. Voors, and et al. N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population Eur Heart J 31 2010 120 127
17. B.H. Stricker, and R.M. Herings Plea for the retention of the Dutch national medical registration (LMR) to provide reliable information regarding public health and healthcare Ned Tijdschr Geneeskd 150 2006 1916 1917
18. H.L. Hillege, V. Fidler, G.F. Diercks, and et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population Circulation 106 2002 1777 1782
19. Statistics Netherlands. Available at: http://www.cbs.nl/en-GB/menu/home/default.htm?Languageswitch=on [data specifically requested]. Accessed July 6, 2015.
20. D. Collett Modelling Binary Data 1999 Chapman & Hall/CRC Boca Raton, FL 24
21. M.V. Perez, P.J. Wang, J.C. Larson, and et al. Risk factors for atrial fibrillation and their population burden in postmenopausal women: Women's Health Initiative observational study Heart 99 2013 1173 1178
22. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
23. R.B. Schnabel, M. Rienstra, L.M. Sullivan, and et al. Risk assessment for incident heart failure in individuals with atrial fibrillation Eur J Heart Fail 15 2013 843 849
24. J.P. Piccini, B.G. Hammill, M.F. Sinner, and et al. Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke Eur Heart J 35 2014 250 256
25. J. Heeringa, D.A. van der Kuip, A. Hofman, and et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam Study Eur Heart J 27 2006 949 953
26. D.G. Wyse, I.C. Van Gelder, P.T. Ellinor, and et al. Lone atrial fibrillation: does it exist? J Am Coll Cardiol 63 2014 1715 1723
27. S.N. Hatem, and P. Sanders Epicardial adipose tissue and atrial fibrillation Cardiovasc Res 102 2014 205 213
28. H.S. Abed, C.S. Samuel, D.H. Lau, and et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation Heart Rhythm 10 2013 90 100
29. H.S. Abed, G.A. Wittert, D.P. Leong, and et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial JAMA 310 2013 2050 2060
30. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, and et al. Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
31. M.R. Patel, K.W. Mahaffey, J. Garg, and et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
32. C.B. Granger, J.H. Alexander, J.J. McMurray, and et al. Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
33. J.S. Healey, S.J. Connolly, M.R. Gold, and et al. Subclinical atrial fibrillation and the risk of stroke N Engl J Med 366 2012 120 129